Vestibular migraine treatment: a comprehensive practical review

D Smyth, Z Britton, L Murdin, Q Arshad, D Kaski - Brain, 2022 - academic.oup.com
Vestibular migraine is an underdiagnosed but increasingly recognized neurological
condition that causes episodic vertigo associated with other features of migraine. It is now …

[HTML][HTML] Fluid biomarkers for monitoring structural changes in polyneuropathies: their use in clinical practice and trials

L Wieske, D Smyth, MP Lunn, F Eftimov, CE Teunissen - Neurotherapeutics, 2021 - Elsevier
Reliable and responsive tools for monitoring disease activity and treatment outcomes in
patients with neuropathies are lacking. With the emergence of ultrasensitive blood …

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial

SJ Stanworth, S Killick, ZK McQuilten… - British journal of …, 2020 - Wiley Online Library
Optimal red cell transfusion support in myelodysplastic syndromes (MDS) has not been
tested and established. The aim of this study was to demonstrate feasibility of recruitment …

Peripherin is a biomarker of axonal damage in peripheral nervous system disease

S Keddie, D Smyth, RYS Keh, MKL Chou, D Grant… - Brain, 2023 - academic.oup.com
Valid, responsive blood biomarkers specific to peripheral nerve damage would improve
management of peripheral nervous system (PNS) diseases. Neurofilament light chain (NfL) …

[HTML][HTML] Comprehensive diagnosis and management of POEMS syndrome

S D'Sa, J Khwaja, S Keddie, RYS Keh, D Smyth… - …, 2022 - journals.lww.com
Abstract Polyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin
changes syndrome is a rare multisystem condition with a range of manifestations which are …

The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain‐Barré syndrome

R McGonigal, ME Cunningham, D Smyth… - Journal of the …, 2023 - Wiley Online Library
Axon degeneration accounts for the poor clinical outcome in Guillain‐Barré syndrome
(GBS), yet no treatments target this key pathogenic stage. Animal models demonstrate anti …

Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation

S Keddie, D Smyth, RYS Keh, L Wieske, M Michael… - Brain, 2024 - academic.oup.com
We are grateful to Dr Berciano for his exposition on the pathogenesis of Guillain-Barré
syndrome (GBS), 1 drawing together our findings on the rise in peripherin with a short and …

Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies

D Smyth, KM Kyaw, A Legister… - Journal of the …, 2021 - jns-journal.com
Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with
leucine-rich glioma-inactivated 1 (LGI-1) antibodies - Journal of the Neurological Sciences Skip …

Toxic neuropathies: a practical approach

D Smyth, C Kramarz, AS Carr, AM Rossor… - Practical …, 2023 - pn.bmj.com
Toxic neuropathies result from exogenous substances damaging the peripheral nerves.
There are numerous causes, including prescribed and recreational drugs, heavy metals …

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome

J Khwaja, R Keh, D Smyth, MP Lunn, S D'Sa, J Sive - EJHaem, 2022 - Wiley Online Library
POEMS syndrome is a rareparaneoplastic disorder driven by an underlying low level
plasma cell dyscrasiaand associated with elevated serum vascular endothelial growth factor …